Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
CNF Investments
AddedFeb 17, 2024
UpdatedJun 28, 2026
CNF Investments

CNF Investments

Operating

CNF Investments LLC: A venture capital firm investing in technology, healthcare, energy, and education.

Location
Bethesda, MD, US
Founded
1997
Firm
Compare
Portfolio
Employees

Investments

Ceros
Ceros

Total Raised

$133.4M

Rounds

5

Series C$14MFebruary 2019
Series B$11MAugust 2016
Svelte Medical Systems
Svelte Medical Systems

Total Raised

$128.4M

Rounds

11

Series Unknown$22MOctober 2018
Private Equity$44.4MFebruary 2016
Series Unknown$5MMarch 2014
Debt Financing$6MNovember 2009
CircleBack
CircleBack
Acquired

Total Raised

$12M

Rounds

1

Series C$12MJuly 2015
Ingo Money
Ingo Money

Total Raised

$26.1M

Rounds

4

Series Unknown$6.7MApril 2015
Vascular Therapies
Vascular Therapies

Total Raised

$90M

Rounds

9

Private Equity$16.2MFebruary 2015
AnyPresence
AnyPresence

Total Raised

$13.6M

Rounds

3

Series B$6MSeptember 2014
SurfWatch Labs
SurfWatch Labs

Total Raised

$12.7M

Rounds

3

Series A$3.5MApril 2014
Viridis Learning
Viridis Learning

Total Raised

$4.5M

Rounds

6

SeedOctober 2013
ReelGenie
ReelGenie

Total Raised

$961k

Rounds

2

Seed$850kJuly 2013
TerraGo Technologies
TerraGo Technologies

Total Raised

$21.4M

Rounds

6

Series C$5.5MMarch 2013
Series Unknown$3.4MApril 2009
Series A$6.3MMay 2007
ViewLift
ViewLift

Total Raised

$44.9M

Rounds

6

Series Unknown$6MJanuary 2013
Revance Therapeutics
Revance Therapeutics
Public

Total Raised

$1.6B

Rounds

17

Series D$45MJune 2011
Overture Technologies
Overture Technologies

Total Raised

$11.4M

Rounds

3

Series C$6MDecember 2008
Series B$3.7MSeptember 2006
Aquestive Therapeutics
Aquestive Therapeutics
Public

Total Raised

$293.1M

Rounds

11

Debt Financing$20MSeptember 2008
Innovative Biosensors
Innovative Biosensors

Total Raised

$20.2M

Rounds

5

Series Unknown$9.5MMay 2008
Verax Biomedical
Verax Biomedical

Total Raised

$64.8M

Rounds

11

Series E$2.5MDecember 2007
Series B$15MOctober 2005
Vital Sensors
Vital Sensors

Total Raised

$1M

Rounds

1

Series Unknown$1MJanuary 2006